Latin America & Caribbean vs Mongolia: Immunization, measles second dose
Latin America & Caribbean
69.3%
in 2024
Mongolia
95.0%
in 2024
Latin America & Caribbean rank
31st
Mongolia rank
33rd
Immunization, measles second dose over time
- Latin America & Caribbean
- Mongolia
How they compare
Mongolia currently reports 95.0% against 69.3% in Latin America & Caribbean, a difference of 25.7%.
That makes Mongolia's figure about 1.4 times Latin America & Caribbean's.
Across all 25 years both countries report, Mongolia has been ahead every year.
Latin America & Caribbean ranks 31st and Mongolia ranks 33rd of 43 groups.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latin America & Caribbean | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.3% | 94.6% | 38.3% | Mongolia |
| 2010s | 68.2% | 97.8% | 29.6% | Mongolia |
| 2020s | 67.4% | 94.8% | 27.4% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles second dose, Latin America & Caribbean or Mongolia?
- Mongolia, at 95.0% against 69.3% in Latin America & Caribbean as of 2024.
- What is the difference in immunization, measles second dose between Latin America & Caribbean and Mongolia?
- 25.7%, with Mongolia ahead.
- How many years of comparable data are there for Latin America & Caribbean and Mongolia?
- 25 years are reported by both, from 2000 to 2024.
- How do Latin America & Caribbean and Mongolia rank globally for immunization, measles second dose?
- Latin America & Caribbean ranks 31st and Mongolia ranks 33rd of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.